Cubist Systematic Strategies’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $318K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $521K | Buy |
|
|||||
|
2024
Q3 | $466K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $76.2K | Sell |
|
|||||
|
2023
Q4 | $603K | Sell |
|
|||||
|
2023
Q3 | $947K | Buy |
|
|||||
|
2023
Q2 | $827K | Buy |
|
|||||
|
2023
Q1 | $183K | Sell |
|
|||||
|
2022
Q4 | $2.47M | Buy |
|
|||||
|
2022
Q3 | $1.71M | Buy |
|
|||||
|
2022
Q2 | $839K | Sell |
|
|||||
|
2022
Q1 | $938K | Sell |
|
|||||
|
2021
Q4 | $1.54M | Buy |
|
|||||
|
2021
Q3 | $664K | Sell |
|
|||||
|
2021
Q2 | $983K | Sell |
|
|||||
|
2021
Q1 | $1.72M | Buy |
|
|||||
|
2020
Q4 | $465K | Sell |
|
|||||
|
2020
Q3 | $810K | Sell |
|
|||||
|
2020
Q2 | $1.19M | Buy |
|
|||||
|
2020
Q1 | $223K | Sell |
|
|||||
|
2019
Q4 | $1.42M | Sell |
|
|||||
|
2019
Q3 | $1.38M | Buy |
|
|||||
|
2019
Q2 | $1.17M | Buy |
|
|||||
|
2019
Q1 | $1.2M | Buy |
|
|||||
|
2018
Q4 | $639K | Sell |
|
|||||
|
2018
Q3 | $1.59M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $36K | Sell |
|
|||||
|
2017
Q3 | $454K | Buy |
|
|||||
|
2017
Q2 | $129K | Sell |
|
|||||
|
2017
Q1 | $196K | Buy |
|
|||||
|
2016
Q4 | $204K | Sell |
|
|||||
|
2016
Q3 | $245K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $191K | Buy |
|